natgillin/translations-raw huggingface dataset:
Specifikt blev der hyppigt set hovedpine, svimmelhed, hoste, kvalme, opkastning, diarré, smerter i arme eller ben samt træthed hos børn og unge.
Specifically, headache, vertigo (spinning feeling), cough, feeling sick, vomiting, diarrhoea, pain in the arms or legs and tiredness were observed commonly in children and adolescents.
Specifikt reducerede prasugrel ikke signifikant hyppigheden af det sammensatte endepunkt kardiovaskulær (CV) død, myokardieinfarkt (MI), apopleksi, akut revaskularisering (UR) eller glykoprotein (GP) IIb/IIIa inhibitor som redningsbehandling indenfor 7 dage efter randomisering hos patienter, der fik prasugrel før koronarangiografi sammenlignet med patienter, som fik den fulde prasugrel loadingdosis på tidspunktet for PCI, og hyppigheden af det væsentlige sikkerhedsmål for alle TIMI større blødninger (CABG og non-CABG hændelser) indenfor 7 dage efter randomisering for alle behandlede patienter var signifikant højere hos de patienter, som fik prasugrel før koronarangiografi i forhold til de patienter, som fik den fulde prasugrel loadingdosis på tidspunktet for PCI.
Specifically, prasugrel did not significantly reduce the frequency of the composite endpoint of cardiovascular (CV) death, myocardial infarction (MI), stroke, urgent revascularization (UR), or glycoprotein (GP) IIb/IIIa inhibitor bailout through 7 days from randomization in subjects receiving prasugrel prior to coronary angiography compared to patients receiving the full loading dose of prasugrel at the time of PCI, and the rate of the key safety objective for all TIMI major bleeding (CABG and non-CABG events) through 7 days from randomization in all treated subjects was significantly higher in subjects receiving prasugrel prior to coronary angiography versus patients receiving the full loading dose of prasugrel at the time of PCI.
Specifikt vil lægen overveje at vaccinere dig mod skoldkopper, hvis du ikke har haft denne sygdom.
In particular, your doctor will consider vaccinating you against chickenpox if you have never had it.
Spectrila fås som et pulver til koncentrat til infusionsvæske, opløsning.
Spectrila is provided as a powder for concentrate for solution for infusion.
Spectrila gives hver 3. dag med drop (ved infusion) i en vene, idet dosis afhænger af patientens alder og legemsoverflade.
Spectrila is given every 3 days by infusion (drip) into a vein, with the dose depending on the patient’s age and body surface area.
Spectrilas virkning og sikkerhed er ikke klarlagt hos Philadelphiakromosom-positive patienter.
Efficacy and safety of Spectrila have not been established in Philadelphia chromosome-positive patients.
Spedra 100 mg tabletter
Spedra 100 mg tablets
Spedra 100 mg tabletter Avanafil
Spedra 100 mg tablets avanafil
Spedra 200 mg tabletter
Spedra 200 mg tablets
Spedra 200 mg tabletter Avanafil
Spedra 200 mg tablets avanafil
Spedra 50 mg tabletter
Spedra 50 mg tablets
Spedra 50 mg tabletter Avanafil
Spedra 50 mg tablets avanafil
Spedra bør ikke anvendes af børn og unge under 18 år.
Spedra should not be taken by children and adolescents under 18 years of age.
Spedra er ikke bestemt til anvendelse hos kvinder.
Spedra is not indicated for use in women.
sPGA på “0” (clear)
sPGA of “0” (clear)
sPGA ”klar” eller ”minimal”, n ( %)
sPGA “clear” or “minimal”, n (%)
sPGA ”klar” eller ”minimal”, n (%)
sPGA “clear” or “minimal”, n (%)
Spids
Barrel
Spids Beskyttelses- (under papir beskyttelsespapir)
Spike (under protective paper)
Spidshætte
Tip-cap
Spidskoncentrationen i plasma opnås 1,5- 2 timer efter oral administration.
Peak plasma concentrations are attained at 1.5 - 2 hours after oral administration.
Spidskoncentrationen i plasma opnås 1,5- 2 timer efter oral administration.
Peak plasma concentrations are attained at 1.5-2 hours after oral administration.
Spild eller affaldsmateriale skal destrueres ved forbrænding.
Any spillage or waste material should be disposed of by incineration.
Spild ved afmåling er ikke
Measurement loss not considered
Spild ved afmåling ikke
Measurement loss not considered
Spildt medicin skal straks tørres op.
Wipe up spillages immediately.
spinal-
haemorrh
spinal-
odium as
Spinal- og/eller epidural-bedøvelse
Spinal and/or epidural anaesthesia
Spinal- og/eller epiduralanæstesi
Spinal and/or epidural anaesthesia
Spinal- og/eller epiduralbedøvelse
Spinal and/or epidural anaesthesia
Spinal-/rygmarvskompression (SCC, Spinal/cervical Cord Compression) med resulterende myelopati, er en kendt og alvorlig komplikation, som kan skyldes MPS VI.
Spinal/cervical cord compression (SCC) with resultant myelopathy is a known and serious complication that can be due to MPS VI.
spinalpunktur og
and post
spinalpunktur og
puncture and
spinocellulært karcinom, basaliom, hudpapillom
squamous cell carcinoma of skin, basal cell carcinoma, skin papilloma
spinosad/milbemycinoxim
spinosad/milbemycin oxime
Spinosads sikkerhed hos drægtige katte (hunkatte) er ikke undersøgt.
The safety of spinosad in pregnant cats (queens) has not been evaluated.
Spiral, som frigiver levonorgestrel
Levonorgestrel-releasing intrauterine system
Spiral, som frigiver levonorgestrel
Levonorgestrel-releasing intrauterine system (IUS)
Spironolakton (spironolactone)
Spironolactone (spironolactonum)
Spironolakton 10 mg Spironolakton 40 mg Spironolakton 80 mg
spironolactone 10 mg spironolactone 40 mg spironolactone 80 mg
Spironolakton metaboliseres hurtigt og fuldstændigt i leveren til dets aktive metabolitter, 7-α- thiomethyl-spironolakton og canrenon, der er de primære metabolitter hos hunden.
Spironolactone is rapidly and completely metabolised by the liver into its active metabolites, 7α- thiomethyl-spironolactone and canrenone, which are the primary metabolites in the dog.
Spironolakton metaboliseres hurtigt og fuldstændigt i leveren til dets aktive metabolitter, 7α- thiomethyl-spironolakton og canrenon, der er de primære metabolitter hos hunden.
Spironolactone is rapidly and completely metabolised by the liver into its active metabolites, 7α- thiomethyl-spironolactone and canrenone, which are the primary metabolites in the dog.
Spironolakton og dets aktive metabolitter (inklusiv 7α-thiomethyl-spironolakton og canrenon) fungerer som en specifik antagonist i forhold til aldosteron, og udøver deres effekt ved kompetitiv binding til mineralokortikoid-receptor, lokaliseret i nyrer, hjerte og blodkar.
Spironolactone and its active metabolites (including 7α-thiomethyl-spironolactone and canrenone) act as specific antagonists of aldosterone, and exert their effects by binding competitively to the mineralocorticoid receptor located in the kidneys, heart and blood vessels.
Spironolakton og dets aktive metabolitter (inklusiv 7α-thiomethyl-spironolakton og canrenon) fungerer som en specifik antagonist i forhold til aldosteron, og udøver deres effekt ved kompetitiv binding til mineralokortikoid-receptorer, lokaliseret i nyrer, hjerte og blodkar.
Spironolactone and its active metabolites (including 7α-thiomethyl-spironolactone and canrenone) act as specific antagonists of aldosterone, and exert their effects by binding competitively to the mineralocorticoid receptor located in the kidneys, heart and blood vessels.
Spironolaktons og dets metabolitters renale effekt fører til et fald i ekstracellulærvolumen og deraf følgende nedsættelse af preload og tryk i venstre forkammer.
The renal effects of spironolactone and its metabolites lead to a decrease in extracellular volume and consequently in a decrease of cardiac preload and left atrial pressure.
Spis et måltid eller et mellemmåltid inden for 10 minutter efter injektionen for at undgå lavt blodsukker.
Eat a meal or snack within 10 minutes of the bolus dose to avoid low blood sugar.
Spis fedtfattigt for at nedsætte sandsynligheden for gener forbundet med kosten (se punkt 4).
Eat lower-fat meals to reduce the chance of diet-related treatment effects (see section 4).
Spis glucosetabletter (druesukker) eller et andet meget sukkerholdigt produkt – såsom slik, kiks eller frugtjuice (medbring for en sikkerheds skyld altid glucosetabletter eller et meget sukkerholdigt produkt).
Eat glucose tablets or another high sugar snack – like sweets, biscuits or fruit juice (always carry glucose tablets or a high sugar snack, just in case).
Spis glucosetabletter (druesukker) eller et andet meget sukkerholdigt produkt, såsom slik, kiks eller frugtjuice (medbring for en sikkerheds skyld altid glucosetabletter eller et meget sukkerholdigt produkt).
Eat glucose tablets or another high sugar snack, like sweets, biscuits or fruit juice (always carry glucose tablets or a high sugar snack, just in case).
Spis glucosetabletter eller et andet meget sukkerholdigt produkt, såsom slik, kiks eller frugtjuice (medbring for en sikkerheds skyld altid glucosetabletter eller et meget sukkerholdigt produkt).
Eat glucose tablets or another high sugar snack, like sweets, biscuits or fruit juice (always carry glucose tablets or a high sugar snack, just in case).
Spis herefter madvarer med langsomt optagelige kulhydrater (som brød eller pasta) for at normalisere dit blodsukker.
Then eat something that has a long-acting effect in raising your blood sugar (such as bread or pasta).
Spis herefter madvarer med langsomt optagelige kulhydrater (såsom f.eks. brød eller pasta) for at normalisere dit blodsukker.
Then eat something that has a long-acting effect in raising your blood sugar (such as bread or pasta).
Spis herefter madvarer med langsomt optagelige kulhydrater (såsom. brød eller pasta) for at normalisere dit blodsukker.
Then eat something that has a long-acting effect in raising your blood sugar (such as bread or pasta).
Spis herefter noget (såsom brød eller pasta), der vil få dit blodsukker til at stige over længere tid.
Then eat something (such as bread or pasta) that will raise your blood sugar over a longer time.
Spis langsomt og spis mindre portioner
Eat slowly and eat smaller portions.
Spis sundere mad, forsøg at undgå krydret eller fed mad og store måltider sent om aftenen, lige inden du går i seng.
Eat healthier food and try to avoid spicy and fatty foods and large meals late before bedtime.
Spis, drik og ryg ikke under håndtering af produktet.
Do not eat, drink or smoke while handling the veterinary medicinal product.
Spis, drik og ryg ikke under håndtering af præparatet.
Do not smoke, drink or eat while handling the veterinary medicinal product.
Spis, drik og ryg ikke under håndtering af veterinærlægemidlet.
Do not eat, drink or smoke while handling the veterinary medicinal product
Spis, drik og ryg ikke under håndteringen af det veterinære lægemiddel.
Do not eat, drink or smoke while handling the veterinary medicinal product.
Spis, drik og ryg ikke, samtidig med at dette veterinærlægemiddel anvendes.
Do not eat, drink or smoke while handling the veterinary medicinal product.
Spiseforstyrrelser, herunder anoreksi
Eating disorders including anorexia
Spiseligt guldblæk: shellac, propylenglycol, stærk ammoniakopløsning, gul jernoxid (E172)
Edible gold ink: shellac, propylene glycol, strong ammonia solution, yellow iron oxide (E172).
Spiseligt hvidt blæk: shellac, propylenglycol, natriumhydroxid, povidon, titandioxid (E171).
Edible white ink: shellac, propylene glycol, sodium hydroxide, povidone, titanium dioxide (E171).
Spiser for lidt eller springer et måltid over
Eat too little or miss a meal.
spiser for lidt eller springer et måltid over bruger for meget Xultophy.
eat too little or miss a meal use too much Xultophy.
Spiser for lidt eller springer et måltid over.
Eat too little or miss a meal.
Spiser mere eller dyrker mindre motion end du plejer, drikker alkohol, får en infektion eller feber, ikke har taget tilstrækkeligt insulin, gentagne gange tager mindre insulin end nødvendigt, glemmer at tage insulin eller stopper med at tage insulin uden at tale med lægen.
Eat more or exercise less than usual; drink alcohol; get an infection or a fever; have not used enough insulin; keep using less insulin than you need; forget to use your insulin or stop using insulin without talking to your doctor.
Spiser mere eller dyrker mindre motion, end du plejer, drikker alkohol, får en infektion eller feber, ikke har taget tilstrækkeligt insulin, gentagne gange tager mindre insulin end du har brug for, glemmer at tage insulin eller stopper med at tage insulin uden at tale med lægen.
Eat more or exercise less than usual; drink alcohol; get an infection or a fever; have not used enough insulin; keep using less insulin than you need; forget to use your insulin or stop using insulin without talking to your doctor.
Spiser mere eller dyrker mindre motion, end du plejer, drikker alkohol, får en infektion eller feber, ikke har taget tilstrækkeligt insulin, gentagne gange tager mindre insulin end nødvendigt, glemmer at tage insulin eller stopper med at tage insulin uden at tale med lægen.
Eat more or exercise less than usual; drink alcohol; get an infection or a fever; have not used enough insulin; keep using less insulin than you need; forget to use your insulin or stop using insulin without talking to your doctor.
Spiser mere end du plejer.
Eat more than usual.
spiser mere end normalt
eat more than usual
Spiser mere, end du plejer
Eat more than usual.
Spiser mere, end du plejer.
Eat more than usual.
Spisevægring, appetitløshed
Anorexia, Decreased appetite
spjættende eller rykkende bevægelser, der ikke kan kontrolleres, uro i benene,
uncontrollable twitching, jerking or writhing movements, restless legs,
spjættende eller rykkende bevægelser,der ikke kan kontrolleres
uncontrollable twitching or jerking movements;
Splenektomerede patienter med AIDS-relateret KS
AIDS-related KS patients with splenectomy
Splenomegali
Splenomegaly
Splenomegali a
Splenomegalya
Splenomegali blev rapporteret som værende relateret til behandling med filgrastim hos < 3% af patienterne.
Splenomegaly was reported to be related to filgrastim therapy in < 3% of patients.
Splenomegali er en direkte effekt af behandlingen med filgrastim.
Splenomegaly is a direct effect of treatment with filgrastim.
Splenomegali Miltruptur
Spenomegaly Splenic rupture
Splenomegali og miltruptur blev også rapporteret.
Splenomegaly and splenic rupture were also reported.
Splenomegalia
Cougha Dyspnoea
Splenomegalia
Splenomegaly a
Splenomegalia
Splenomegalya
Splenomegalia Anæmi
Splenomegalya Anaemia
Splenomegalia, e
Splenomegalya, e
Split influenzavirus*, inaktiveret indeholdende antigen svarende til:
Split influenza virus*, inactivated, containing antigen equivalent to:
Split influenzavirus*, inaktiveret, indeholdende antigen svarende til:
Split influenza virus*, inactivated containing antigen equivalent to:
Split influenzavirus, inaktiveret, indeholdende antigen svarende til:
Split influenza virus inactivated, containing antigen equivalent to:
Split influenzavirus, inaktiveret, indeholdende antigen svarende til:
Split influenza virus, inactivated, containing antigen equivalent to:
Split influenzavirus, inaktiveret, indeholdende antigen svarende til: A/California/07/2009 (H1N1) afledt fra NYMC X-179A-stamme 3,75 mikrogram* AS03-adjuvans bestående af squalen, DL-α-tocopherol og polysorbat 80
Split influenza virus inactivated, containing antigen equivalent to: A/California/07/2009 (H1N1) derived strain used NYMC X-179A 3.75 micrograms* AS03 adjuvant composed of squalene, DL--tocopherol and polysorbate 80
Split influenzavirus, inaktiveret, indeholdende antigen svarende til: A/VietNam/1194/2004 (H5N1)-lignende stamme (NIBRG-14) 3,75 mikrogram*
Split influenza virus, inactivated, containing antigen equivalent to: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14) 3.75 micrograms
Split influenzavirus, inaktiveret, indeholdende antigen* svarende til
Split influenza virus, inactivated, containing antigen* equivalent to
Split influenzavirus, inaktiveret, indeholdende antigen* svarende til:
Split influenza virus, inactivated, containing antigen* equivalent to
Split influenzavirus, inaktiveret, indeholdende antigen* svarende til: A/California/7/2009 (H1N1)v-lignende stamme (X-179A) 3,75 mikrogram**
A/California/7/2009 (H1N1)v-like strain (X-179A) 3.75 micrograms
Split influenzavirus, inaktiveret, indeholdende antigen* svarende til: A/California/7/2009 (H1N1)v-lignende stamme (X-179A) 3,75 mikrogram**
Split influenza virus inactivated, containing antigen* equivalent to: A/California/7/2009 (H1N1)v like strain (X-179A) 3.75 micrograms
Split influenzavirus, inaktiveret, indeholdende antigen* svarende til: A/Indonesia/05/2005 (H5N1) 3,75 mikrogram**
Split influenza virus inactivated, containing antigen* equivalent to: A/Indonesia/05/2005 (H5N1) 3.75 micrograms
Split influenzavirus, inaktiveret, indeholdende antigen* svarende til: A/VietNam/1194/2004 (H5N1)-lignende stamme (NIBRG-14) 3,75 mikrogram**
Split influenza virus inactivated, containing antigen* equivalent to: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14) 3.75 micrograms
Split influenzavirus, inaktiveret, indeholdende antigen* svarende til: A/VietNam/1194/2004 (H5N1)-lignende stamme (NIBRG-14) 3,75 mikrogram**
Split influenza virus, inactivated, containing antigen* equivalent to: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14) 3.75 micrograms
Spm.
Q.
Spm.: Hvor bør jeg opbevare min NutropinAq Pen?
Q: Where should I store my NutropinAq Pen?
Spm: Hvad betyder et blinkende ‘bt’ i displayet?
Q: What does a blinking „bt‟ mean in the LCD?
Spm: Skal jeg skifte penkanyle hver gang, jeg bruger min NutropinAq Pen?
Q: Do I need to change the needle every time I use my NutropinAq Pen?
spondylartropati, Sjögrens syndrom, artritis, myopati
spondyloarthropathy, Sjogren’s syndrome, arthritis, myopathy
spontan abort
abortion
Spontan abort
Miscarriage
Spontan abort
Spontaneous Abortion
Spontan blødning eller blå mærker (tegn på lavt niveau af blodplader, også kendt som trombocytopeni)
Spontaneous bleeding or bruising (signs of low level of platelets, also known as thrombocytopenia)
Spontan blødning eller blå mærker, tegn på lavt niveau af blodplader (trombocytopeni)
Spontaneous bleeding or bruising, signs of low level of platelets (thrombocytopenia)
Spontan blødning fra øjne, endetarm, tandkød eller i bughulen omkring de indre organer
Spontaneous bleeding from the eye, rectum, gums or in the abdomen around the internal organs
Spontan erektion
Spontaneous penile erection
Spontan forværring af kronisk hepatitis B er forholdsvist almindeligt og er karakteriseret ved kortvarige stigninger i serum-ALAT.
Spontaneous exacerbations in chronic hepatitis B are relatively common and are characterised by transient increases in serum ALT.
Spontan peniserektion, menstruationsforstyrrelser
Spontaneous penile erection, Menstrual disorder
Spontane aborter
Miscarriage
Spontane aborter (frekvens på 45- 49%) og medfødte misdannelser (estimeret frekvens på 23-27%) er blevet rapporteret efter mycophenolatmofetil eksponering under graviditet.
Spontaneous abortion (rate of 45-49%) and congenital malformations (estimated rate of 23-27%) have been reported following MMF exposure during pregnancy.
Spontane aborter (frekvens på 45-49 %) og medfødte misdannelser (estimeret frekvens på 23-27 %) er blevet rapporteret efter mycophenolatmofetil-eksponering under graviditet.
Spontaneous abortion (rate of 45-49%) and congenital malformations (estimated rate of 23-27%) have been reported following MMF exposure during pregnancy.
Spontane aborter er rapporteret hos 45 til 49 % af de gravide kvinder, som var eksponeret for mycophenolatmofetil, sammenlignet med en hyppighed på 12 til 33 % hos patienter, der havde gennemgået en transplantation af solide organer, og som blev behandlet med andre immunsuppressiva end mycophenolatmofetil.
Spontaneous abortions have been reported in 45 to 49% of pregnant women exposed to mycophenolate mofetil, compared to a reported rate of between 12 and 33% in solid organ transplant patients treated with immunosuppressants other than mycophenolate mofetil.
Spontane symptomer, som vurderes at have en mulig sammenhæng med vaccinationen blev usædvanligvis rapporteret og bestod af kulderystelser, andre reaktioner fra injektionsstedet og maculo- papular udslæt.
Unsolicited symptoms considered to be at least possibly related to vaccination were uncommonly reported and consisted of rigors, other injection site reaction and maculo-papular rash.
Spontante aborter er rapporteret hos 45 til 49 % af de gravide kvinder, som var eksponeret for mycophenolatmofetil, sammenlignet med en hyppighed på 12 til 33 % hos patienter , der havde gennemgået en transplantation af solide organer, og som blev behandlet med andre immunsuppressiva end mycophenolatmofetil.
Spontaneous abortions have been reported in 45 to 49% of pregnant women exposed to mycophenolate mofetil, compared to a reported rate of between 12 and 33% in solid organ transplant patients treated with immunosuppressants other than mycophenolate mofetil.
Sporbare mængder af østrogener er fundet i mælken hos mødre, der fik konjugerede østrogener.
Detectable amounts of oestrogens have been identified in the milk of mothers receiving CE.
Sporbarhed af NeoRecormon:
Traceability of NeoRecormon
Sporbarhed af patienter og brug afidentifikatorer
Traceability of patients and use of identifiers
Sportsudøvere bør oplyses om, at behandling med pseudoephedrinsulfat kan føre til positiv dopingtest.
Athletes should be informed that treatment with pseudoephedrine sulphate could lead to positive doping tests.
Spot- on, opløsning
Spot-on solution
Spot-on
Spot-on solution
Spot-on
Spot-on use
Spot-on anvendelse
moxidectin
Spot-on anvendelse.
Spot-on use
Spot-on applikator (COC) med polymerhætte
Spot-on applicator (COC) with polymer cap
Spot-on opløsning
Spot-on solution.
Spot-on opløsning
Spot-on-solution
Spot-on opløsning til påføring på huden
Spot-on solution for external application to the skin
Spot-on opløsning.
Spot-on use.
Spot-on opløsningen og tabletterne fås i forskellige styrker til hunde og katte af forskellig vægt.
The spot-on solution and tablets are available in different strengths for dogs and cats of different weights.
Spot-on pipetten består af en klar gul polypropylenskal med en bleg gul bagside af aluminium folie overtrukket med en polyethylen terephthalat film.
The spot on pipette is composed of a bright yellow polypropylene shell, with a pale yellow aluminium foil back coated with a polyethylene terephthalate film.
Spot-on til påføring på huden.
Spot-on use for external application to the skin
Spot-on til påføring på hundens hud .
For spot-on use for external application to the dog’s skin.
Spot-on til udvortes brug.
Spot-on use for external application.
Spot-on, opløsning
Spot-on solution.
Spot-on, opløsning Intervet UK Limited Walton Manor, Walton Milton Keynes
Spot-on solution Intervet UK Limited Walton Manor, Walton, Milton Keynes,
Spot-on, opløsning.
Spot-on solution
Spot-on- anvendelse
Spot-on use
Spot-on- applikator (PE/Alu/PE)
Spot-on applicator (PE/Alu/PE)
Spot-on- opløsning
Spot-on solution
Spot-on-anvendelse
Spot-on use
Spot-on-applikator
Spot-on applicator
Spot-on-applikator-etiket
Spot-on applicator label
Spot-on-applikatoren er fremstillet af et flerlagskompleks bestående af aluminium og polyetylen (PE) med HDPE og topforseglet med en kompleks folie (aluminium/polyester/forseglende PE-lag).
Spot-on applicator made of a multilayered complex of aluminium and polyethylene (PE) with a head made of HDPE, top-sealed with a liner complex (aluminium/polyester/sealable PE layer).
Spot-on-opløsning
Spot-on solution
Spot-on-opløsning.
Spot-on solution.
Spray
Chicken
Spray RevitaCAM ind i hundens mund
Spray RevitaCAM into dog’s mouth
Spray- sæt, der skal anvendes
Spray set to be used
Spray-afstanden til vævet og trykket skal være inden for de intervaller, som producenten anbefaler (se tabellen under punktet Brugsanvisning).
Spray distance from tissue and pressure should be within the ranges recommended by the manufacturer (see table in Section Instructions for Use).
Spray-applikation af EVICEL må kun anvendes, hvis det er muligt nøjagtigt at bedømme spray- afstanden, især under laparoskopi.
EVICEL spray application should only be used if it is possible to accurately judge the spray distance, especially during laparoscopy.